Infection and Immunity, April 2003, p. 2272-2275, Vol. 71, No. 4
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.4.2272-2275.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Mucosal Immunization with a Genetically Engineered Pertussis Toxin S1 Fragment-Cholera Toxin Subunit B Chimeric Protein
Song F. Lee,1,2* Scott A. Halperin,2,3 Danny F. Salloum,2 Ann MacMillan,3 and Annette Morris3
Department of Applied Oral Sciences, Faculty of Dentistry,1
Department of Microbiology & Immunology, Dalhousie University,2
Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada B3H 3J53
Received 6 November 2002/
Returned for modification 22 November 2002/
Accepted 13 December 2002
A chimeric protein consisting of a divalent pertussis toxin (PT) S1 fragment linked to the cholera toxin (Ctx) A2B fragment was constructed. The chimera induced a mucosal immunoglobulin A (IgA) and a serum IgG immune response to PT and CtxB in BALB/c mice following intranasal immunization. The immune sera neutralized PT in vitro. In the mouse model of Bordetella pertussis respiratory infection, the chimera-immunized animals showed a significant reduction in bacterial lung counts (P = 0.01) from that of the sham control group. Thus, a divalent S1 fragment CtxA2B chimera is an immunogenic antigen and can elicit a protective immunity.
* Corresponding author. Mailing address: Department of Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, Halifax, Nova Scotia, Canada B3H 3J5. Phone: (902) 494-8799. Fax: (902) 494-6621. E-mail: song.lee{at}dal.ca.
Editor: J. T. Barbieri
Infection and Immunity, April 2003, p. 2272-2275, Vol. 71, No. 4
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.4.2272-2275.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fry, S. R., Chen, A. Y., Daggard, G., Mukkur, T. K. S.
(2008). Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection. J Med Microbiol
57: 28-35
[Abstract]
[Full Text]
-
Hussein, A. H., Davis, E. M., Halperin, S. A., Lee, S. F.
(2007). Construction and Characterization of Single-Chain Variable Fragment Antibodies Directed against the Bordetella pertussis Surface Adhesins Filamentous Hemagglutinin and Pertactin. Infect. Immun.
75: 5476-5482
[Abstract]
[Full Text]
-
Mansour, M., Brown, R. G., Morris, A., Smith, B., Halperin, S. A.
(2007). Improved Efficacy of a Licensed Acellular Pertussis Vaccine, Reformulated in an Adjuvant Emulsion of Liposomes in Oil, in a Murine Model. CVI
14: 1381-1383
[Abstract]
[Full Text]
-
Tinker, J. K., Erbe, J. L., Holmes, R. K.
(2005). Characterization of Fluorescent Chimeras of Cholera Toxin and Escherichia coli Heat-Labile Enterotoxins Produced by Use of the Twin Arginine Translocation System. Infect. Immun.
73: 3627-3635
[Abstract]
[Full Text]
-
Areas, A. P. M., Oliveira, M. L. S., Miyaji, E. N., Leite, L. C. C., Ho, P. L.
(2005). Intradermal Immunization of Mice with Cholera Toxin B-Pneumococcal Surface Protein A Fusion Protein Is Protective against Intraperitoneal Challenge with Streptococcus pneumoniae. Infect. Immun.
73: 3810-3813
[Full Text]
-
Lee, C. W., Lee, S. F., Halperin, S. A.
(2004). Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii. Appl. Environ. Microbiol.
70: 4569-4574
[Abstract]
[Full Text]
-
Kamachi, K., Arakawa, Y.
(2004). Expression of a C Terminally Truncated Form of Pertussis Toxin S1 Subunit Effectively Induces Protection against Pertussis Toxin following DNA-Based Immunization. Infect. Immun.
72: 4293-4296
[Abstract]
[Full Text]
-
Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., Lustgarten, J.
(2004). Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses. Infect. Immun.
72: 2810-2816
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.